Remimazolam Protects Against LPS-Induced Endotoxicity Improving Survival of Endotoxemia Mice
Remimazolam is a new benzodiazepine of sedative drugs with an ultra-short-acting anesthetic effect, commonly used for critically ill patients (especially septic patients) in intensive care units (ICUs). Although some anesthetics have been reported to show certain anti-inflammatory effects, the role...
Main Authors: | Xiaolei Liu, Shaoping Lin, Yiyue Zhong, Jiaojiao Shen, Xuedi Zhang, Shuhua Luo, Li Huang, Liangqing Zhang, Shuangnan Zhou, Jing Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.739603/full |
Similar Items
-
Benefits of remimazolam as an anesthetic sedative for older patients: A review
by: Ning Jin, et al.
Published: (2024-02-01) -
Profile of Remimazolam in Anesthesiology: A Narrative Review of Clinical Research Progress
by: Wang M, et al.
Published: (2022-10-01) -
Remimazolam Compared to Propofol During Hysteroscopy: A Safety and Efficacy Analysis
by: Shunyi Fan, et al.
Published: (2023-03-01) -
Remimazolam: pharmacological characteristics and clinical applications in anesthesiology
by: Kyung Mi Kim
Published: (2022-01-01) -
Long-term delayed emergence after remimazolam-based general anesthesia: a case report
by: Tsubasa Takemori, et al.
Published: (2022-10-01)